Rebecca H. Ritchie

9.2k total citations · 3 hit papers
162 papers, 7.1k citations indexed

About

Rebecca H. Ritchie is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Rebecca H. Ritchie has authored 162 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Cardiology and Cardiovascular Medicine, 77 papers in Molecular Biology and 44 papers in Physiology. Recurrent topics in Rebecca H. Ritchie's work include Cardiovascular Function and Risk Factors (54 papers), Nitric Oxide and Endothelin Effects (33 papers) and Cardiac Ischemia and Reperfusion (21 papers). Rebecca H. Ritchie is often cited by papers focused on Cardiovascular Function and Risk Factors (54 papers), Nitric Oxide and Endothelin Effects (33 papers) and Cardiac Ischemia and Reperfusion (21 papers). Rebecca H. Ritchie collaborates with scholars based in Australia, United States and United Kingdom. Rebecca H. Ritchie's co-authors include E. Dale Abel, Julie R. McMullen, Cheng Xue Qin, Karina Huynh, Lea M.D. Delbridge, Bianca C. Bernardo, David M. Kaye, Owen L. Woodman, Barbara K. Kemp‐Harper and Kimberley M. Mellor and has published in prestigious journals such as Circulation, Nature Communications and Journal of the American College of Cardiology.

In The Last Decade

Rebecca H. Ritchie

156 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways

2014 471 citations Karina Huynh, Julie R. McMullen et al. Pharmacology & Therapeutics profile →
Basic Mechanisms of Diabetic Heart Disease

2020 467 citations Rebecca H. Ritchie et al. profile →
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy

2018 265 citations Rebecca H. Ritchie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rebecca H. Ritchie Australia	46	2.9k	2.9k	1.5k	1.4k	916	162	7.1k
Sihem Boudina United States	35	3.0k 1.0×	3.9k 1.4×	2.7k 1.7×	787 0.6×	807 0.9×	66	7.7k
Tomomi Ide Japan	47	3.3k 1.1×	4.0k 1.4×	1.5k 1.0×	399 0.3×	855 0.9×	179	8.6k
Taixing Cui United States	50	1.6k 0.5×	4.0k 1.4×	1.6k 1.1×	755 0.6×	625 0.7×	114	7.1k
David Grieve United Kingdom	34	1.9k 0.6×	2.0k 0.7×	1.6k 1.1×	795 0.6×	651 0.7×	91	5.3k
Bodo Levkau Germany	52	1.8k 0.6×	4.8k 1.6×	838 0.5×	1.1k 0.8×	2.0k 2.1×	157	9.2k
Edward P. Feener United States	43	1.4k 0.5×	2.8k 1.0×	1.3k 0.9×	1.1k 0.8×	697 0.8×	94	6.7k
Marc van Bilsen Netherlands	44	2.4k 0.8×	3.6k 1.2×	1.4k 0.9×	639 0.5×	767 0.8×	107	6.4k
Atsunori Kashiwagi Japan	44	1.2k 0.4×	2.0k 0.7×	1.9k 1.3×	1.7k 1.2×	929 1.0×	158	7.0k
Christoph Maack Germany	44	3.8k 1.3×	4.2k 1.5×	1.0k 0.7×	564 0.4×	824 0.9×	165	7.9k
Yoshihiko Nishio Japan	42	1.0k 0.3×	1.8k 0.6×	1.4k 0.9×	1.2k 0.9×	879 1.0×	154	5.2k

Countries citing papers authored by Rebecca H. Ritchie

Since Specialization

Citations

This map shows the geographic impact of Rebecca H. Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca H. Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca H. Ritchie more than expected).

Fields of papers citing papers by Rebecca H. Ritchie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca H. Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca H. Ritchie. The network helps show where Rebecca H. Ritchie may publish in the future.

Co-authorship network of co-authors of Rebecca H. Ritchie

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca H. Ritchie. A scholar is included among the top collaborators of Rebecca H. Ritchie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca H. Ritchie. Rebecca H. Ritchie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bagher, Pooneh, Hiroe Toba, Merry L. Lindsey, et al.. (2025). Guidelines for diet-induced models of cardiometabolic syndrome. American Journal of Physiology-Heart and Circulatory Physiology. 329(4). H974–H988.

Jackson, Kristy L., Haoyun Fang, Feng Tang, et al.. (2025). Annexin-A1 deficiency uncovers female-specific pathways in blood pressure control and cardiovascular remodeling in mice. Communications Biology. 8(1). 955–955.

Ferens, Dorota, Ekaterina Salimova, Philip E. Thompson, et al.. (2024). Insulin Regulated Aminopeptidase (IRAP) Inhibition – A Novel Treatment for Diabetes-Induced Cardiovascular Disease. Heart Lung and Circulation. 33. S480–S480.

Jackson, Kristy L., Haoyun Fang, Bethany Claridge, et al.. (2024). Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage. Cardiovascular Research. 120(11). 1336–1350. 6 indexed citations

Mohan, Muthukumar, Eoin Brennan, Helen Kiriazis, et al.. (2024). Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction. Cardiovascular Diabetology. 23(1). 413–413. 5 indexed citations

Jackson, Kristy L., Feng Tang, Cameron J. Nowell, et al.. (2024). The pro‐resolving mediator, annexin A1 regulates blood pressure, and age‐associated changes in cardiovascular function and remodeling. The FASEB Journal. 38(3). e23457–e23457. 7 indexed citations

Nold‐Petry, Claudia A., Simon G. Royce, Owen L. Woodman, et al.. (2023). The small‐molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti‐inflammatory in mouse precision‐cut lung slices. British Journal of Pharmacology. 181(14). 2287–2301. 4 indexed citations

Deo, Minh, Helen Kiriazis, D. Donner, et al.. (2023). A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology. 324(2). H241–H257. 10 indexed citations

Qin, Cheng Xue, Minh Deo, Sarah A. Marshall, et al.. (2022). Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance. British Journal of Pharmacology. 179(16). 4117–4135. 7 indexed citations

10.

Prakoso, Darnel, Shiang Y. Lim, Jeffrey R. Erickson, et al.. (2021). Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart. Cardiovascular Research. 118(1). 212–225. 66 indexed citations

11.

Ritchie, Rebecca H., et al.. (2021). The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?. Pharmacology & Therapeutics. 232. 108008–108008. 35 indexed citations

12.

Ramalingam, Anand, Siti Balkis Budin, Norsyahida Mohd Fauzi, Rebecca H. Ritchie, & Satirah Zainalabidin. (2021). Targeting mitochondrial reactive oxygen species-mediated oxidative stress attenuates nicotine-induced cardiac remodeling and dysfunction. Scientific Reports. 11(1). 13845–13845. 36 indexed citations

13.

Qin, Cheng Xue, Sarah Rosli, Minh Deo, et al.. (2019). Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac2-26, Against Myocardial Infarction. Frontiers in Pharmacology. 10. 269–269. 31 indexed citations

14.

Deora, Girdhar Singh, Cheng Xue Qin, Elizabeth A. Vecchio, et al.. (2019). Substituted Pyridazin-3(2H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists. Journal of Medicinal Chemistry. 62(10). 5242–5248. 19 indexed citations

15.

Bubb, Kristen J., Cindy Kok, Owen Tang, et al.. (2016). Abstract 15540: NRF2 Upregulation Attenuates Post-Infarct Ventricular Remodeling by Modifying Redox Signalling. Circulation. 134. 1 indexed citations

16.

Blasio, Miles J. De, Darnel Prakoso, Cheng Xue Qin, et al.. (2016). Abstract 15267: Cardiac-Specific Insulin-Like Growth Factor-1 Receptor (IGF-1R) Expression Targets Maladaptive Hexosamine Biosynthesis and O-Linked GlcNAc Modification of Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA2a) in Diabetic Myocardium. Circulation. 134. 1 indexed citations

17.

Qin, Cheng Xue, Hooi Hooi Ng, Maria Jelinic, et al.. (2016). Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries. Pharmacological Research. 111. 325–335. 26 indexed citations

18.

Blasio, Miles J. De, Karina Huynh, Cheng Xue Qin, et al.. (2015). Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling. Free Radical Biology and Medicine. 87. 137–147. 69 indexed citations

19.

Miller, Alyson A., Karen L. Andrews, Jennifer C. Irvine, et al.. (2010). Nitroxyl (HNO) as a Vasoprotective Signaling Molecule. Antioxidants and Redox Signaling. 14(9). 1675–1686. 58 indexed citations

20.

Ritchie, Rebecca H., Xiaolu Sun, & G. J. Dusting. (1999). LIPOCORTIN‐1 PRESERVES MYOCARDIAL RESPONSIVENESS TO β‐ADRENERGIC STIMULATION IN RAT PAPILLARY MUSCLE. Clinical and Experimental Pharmacology and Physiology. 26(7). 522–524. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact